NovoCure Ltd — Director's Dealing 2019

Jan 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-01-09

Reporting Person: Shah Pritesh (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-09	Ordinary Shares	M	8988	$14.37	Acquired	26075	Direct
2019-01-09	Ordinary Shares	S	5965	$40.00	Disposed	20110	Direct
2019-01-09	Ordinary Shares	S	3023	$40.01	Disposed	17087	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-09	Options to Buy Ordinary Shares	$14.37	M	8988	Acquired	2025-02-23	Ordinary Shares (8988)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.

F2: Options exercised were fully vested as of the date hereof.